Disease/Infection News

RSS

AI predicts if or when a patient could die of cardiac arrest

In a recent study published in the journal Nature Cardiovascular Research, researchers used deep learning (DL) assessment of the scarring in the heart to predict arrhythmia-associated sudden death survival.

24 May 2022

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the effectiveness of oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals, molnupiravir (Lagevrio) or nirmatrelvir/ritonavir (Paxlovid) in a real-world setting.

24 May 2022

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

In a recent study published in the journal Cell, researchers demonstrated that antibodies generated due to breakthrough infection (BTI) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) new variant of concern (VOC) Omicron in vaccinated individuals could neutralize all VOCs.

24 May 2022

BNT162b2 vaccine induces robust SARS-CoV-2 immunity in children

In a recent study posted to the medRxiv* pre-print server, researchers evaluated coronavirus disease 2019 (COVID-19) vaccine-induced humoral immune response in five to 11-year-old children.

23 May 2022

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies from researchers at the Case Western Reserve University School of Medicine.

23 May 2022

Study reveals the cross-protective role of Omicron infection in vaccinated individuals

A new study compares the cross-protective humoral responses to different SARS-CoV-2 variants induced by vaccination or infection.

23 May 2022

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

Researchers evaluate the persistence of anti-SARS-CoV-2 IgA and IgG in breast milk before and after in vitro gastrointestinal digestion.

23 May 2022

ATLAS assay reveals SARS-CoV-2 variant T-cell responses

Researchers utilize the ATLAS screening assay to reveal the antigen response profiles of T-cells to different SARS-CoV-2 variants.

23 May 2022

Health authorities must revolutionize testing to deal with future covid-19 prevalence

Dealing with lower covid-19 levels will require improved understanding of what diagnostic tests are best used for. It will also need more accurate tests, but as testing demand will fall, delivering that needs incentive-based support.

23 May 2022

Emergency department plays vital role in investigating the accuracy of COVID-19 diagnostic tests

The Department of Emergency Medicine at Washington University School of Medicine in St. Louis played a key role in investigating the accuracy of many different types of COVID-19 diagnostic tests administered in real-life conditions.

23 May 2022

Emergence of monkeypox: Control measures and concerns

Monkeypox, a virus that causes pus-filled blisters, has been detected in several countries, including the United States, Canada, Australia and some European nations.

23 May 2022

UVA scientists make progress in their longstanding efforts to combat tuberculosis

As headlines focus on COVID-19 and, now, monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world. Approximately 1.5 million people died of tuberculosis in 2020, the World Health Organization reports.

23 May 2022

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

A new study aimed to evaluate the immunostimulatory potential of mRNA vaccines in AGS patients.

23 May 2022

CDC scientists partner with Massachusetts Department of Public Health to investigate a monkeypox case

Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Massachusetts Department of Public Health to investigate a case of monkeypox in a Massachusetts resident who had recently traveled to Canada by private transportation.

23 May 2022

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

23 May 2022

Study suggests that recall of B cell memory may depend on relative locations of prime and boost immunization

A new study investigated whether a specific population of local Bmem cells in the proximal LNs produce secondary GC responses that are different from those at distal sites and if the location in humoral immunity is relevant only to nonlymphoid tissues.

23 May 2022

Disease/Infection News

AI predicts if or when a patient could die of cardiac arrest

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

Omicron vaccine breakthrough infections induce potent cross-reactive antibodies

BNT162b2 vaccine induces robust SARS-CoV-2 immunity in children

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Study reveals the cross-protective role of Omicron infection in vaccinated individuals

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

ATLAS assay reveals SARS-CoV-2 variant T-cell responses

Health authorities must revolutionize testing to deal with future covid-19 prevalence

Emergency department plays vital role in investigating the accuracy of COVID-19 diagnostic tests

Emergence of monkeypox: Control measures and concerns

UVA scientists make progress in their longstanding efforts to combat tuberculosis

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

CDC scientists partner with Massachusetts Department of Public Health to investigate a monkeypox case

University of Minnesota receives $66 million to establish new antiviral drug discovery center

Study suggests that recall of B cell memory may depend on relative locations of prime and boost immunization

Readiness of the United States to combat known and unknown future infectious pathogens

Investigation of long-COVID in children with immunodeficiency

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

Real-world vaccine effectiveness of mRNA-1273 and BNT1262b2 in immunocompromised adults

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News